Prosecution Insights
Last updated: November 16, 2026

Reprise Biomedical Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Reprise Biomedical Inc. has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This action is under the review of a distinct examiner and is located in 1 distinct art unit. This indicates a singular technical focus for the company's current prosecution. The concentration of the portfolio in a single art unit suggests a specific technical focus within the medical devices field.

The busiest examiner for the portfolio is MUTCHLER, CHRISTOPHER JOHN, who is handling 1 pending office action. This represents the total volume of pending office actions for the company. Because there is only one distinct examiner and one distinct art unit, the prosecution strategy is centralized. Practitioners should focus on the specific examination patterns of MUTCHLER, CHRISTOPHER JOHN and the standards of the art unit.

The presence of the pending office action in the Medical Devices & Mechanical Engineering sector suggests a focused intellectual property approach. For a practitioner, this concentration simplifies the management of the portfolio but increases the impact of the individual examiner's perspective. Success will depend on a deep understanding of the art unit's prior art landscape and the examiner's past behavior.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MUTCHLER, CHRISTOPHER JOHN 1 56.3% +21.3%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18720800 Tunnel Filler Device And Methods Of Use MUTCHLER, CHRISTOPHER JOHN 27d

Top Art Units

Art UnitApps
3792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18720800 Tunnel Filler Device And Methods Of Use MUTCHLER, CHRISTOPHER JOHN 3792 §103 Non-Final OA 27d Pending Jun 17, 2024

Managing Reprise Biomedical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Reprise Biomedical Inc. have?

Reprise Biomedical Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Reprise Biomedical Inc. applications?

Christopher John Mutchler has the most, with 1 of Reprise Biomedical Inc.'s pending office actions.

What technology area are Reprise Biomedical Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month